Biotech

All Articles

BioAge eyes $180M coming from IPO, private placement for excessive weight tests

.BioAge Labs is looking at about $180 thousand in preliminary earnings from an IPO and a private pla...

Merck's LAG-3 combination neglects colon cancer cells stage 3 research study

.A try through Merck &amp Co. to unlock the microsatellite steady (MSS) metastatic colon cancer cell...

Spanish VC shuts $200M life scientific researches fund

.Spain-based Asabys Allies has shut a fund of 180 thousand euros ($ 200 thousand), loan that will go...

BioAge generates $198M from IPO as being overweight biotech joins Nasdaq

.BioAge Labs is producing virtually $200 thousand by means of its Nasdaq IPO this morning, with the ...

Acadia brings BMS vet on board as chief executive officer-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable management hirings, firings and a...

Cassava spends $40M over purportedly deceiving Alzheimer's upgrade

.Cassava Sciences has accepted to spend $40 million to resolve an inspection right into claims it cr...

Merck bags alternatives on Evaxion's AI-designed vaccination prospects

.Merck &amp Co. has grabbed options on two Evaxion Biotech vaccination candidates, paying for $3.2 t...

Enanta's RSV antiviral crushes virus-like tons in challenge research study

.Enanta Pharmaceuticals has actually connected its own respiratory system syncytial infection (RSV) ...

Biogen cans SAGE-324 partnership after vital shake stop working

.Biogen has actually conducted the last ceremonies to its collaboration with Sage Rehabs on SAGE-324...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel acquistion credit ratings

.On the exact same time that some Parkinson's disease medications are being actually disputed, AbbVi...